Results 231 to 240 of about 88,199 (267)
Some of the next articles are maybe not open access.
Hydroxychloroquine Retinopathy
American Journal of Ophthalmology, 1991We analyzed ocular findings from two patients (aged 49 and 60 years) with hydroxychloroquine (Plaquenil, Winthrop Pharmaceuticals, Division of Sterling Drug, Inc., New York, New York) retinopathy. Both patients were treated for systemic lupus erythematosus; one patient was treated with 400 to 800 mg of hydroxychloroquine per day (6.1 to 12.2 mg/kg of ...
A, Weiner +4 more
openaire +2 more sources
Archives of Ophthalmology, 1982
Ninety-nine patients were treated with hydroxychloroquine sulfate for connective tissue diseases during a seven year period. All patients received the medication for at least one year and most were treated with a daily dosage of 400 mg. Four patients experienced toxic effects, but no patient sustained permanent loss of visual acuity.
D R, Tobin, G, Krohel, R I, Rynes
openaire +2 more sources
Ninety-nine patients were treated with hydroxychloroquine sulfate for connective tissue diseases during a seven year period. All patients received the medication for at least one year and most were treated with a daily dosage of 400 mg. Four patients experienced toxic effects, but no patient sustained permanent loss of visual acuity.
D R, Tobin, G, Krohel, R I, Rynes
openaire +2 more sources
Hydroxychloroquine Retinopathy
Archives of Ophthalmology, 1999R K, Maturi +4 more
openaire +2 more sources